Processing

Please wait...

Settings

Settings

1. WO2018136490 - COMPOSITIONS AND METHODS FOR COMMON COLDS

Publication Number WO/2018/136490
Publication Date 26.07.2018
International Application No. PCT/US2018/014011
International Filing Date 17.01.2018
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
702
Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
715
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
733
Fructosans, e.g. inulin
[IPC code unknown for A61K 35/742]
A61K 31/702 (2006.01)
A61K 31/733 (2006.01)
A61K 35/742 (2015.01)
CPC
A61K 2035/115
A61K 31/366
A61K 31/375
A61K 31/59
A61K 31/592
A61K 31/593
Applicants
  • M. ALPHABET 3, LLC [US/US]; 16354 Vintage Oaks Lane Delray Beach, FL 33484, US
Inventors
  • HOWARD, Fein; US
  • BERLIN, Joshua, M.; US
Agents
  • NORTON, Vicki, G.; US
Priority Data
62/447,38917.01.2017US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) COMPOSITIONS AND METHODS FOR COMMON COLDS
(FR) COMPOSITIONS ET PROCÉDÉS POUR RHUME BANAL
Abstract
(EN)
This disclosure relates to pharmaceutical compositions for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold. The pharmaceutical composition can comprise a probiotic formulation of non-pathogenic bacteria, vitamin C and vitamin D along with a pharmaceutically acceptable excipient or filler. A method of for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold is also disclosed in which a patient in need of a treatment for preventing, treating, reducing the duration, or reducing the severity of symptoms of the common cold is identified. The pharmaceutical composition can then be administered orally to the patient.
(FR)
La présente invention concerne des compositions pharmaceutiques pour la prévention, le traitement, la réduction de la durée, ou la réduction de la gravité de symptômes du rhume banal. La composition pharmaceutique peut comprendre une formulation probiotique de bactéries non pathogènes, de vitamine C et de vitamine D conjointement avec un excipient ou une charge pharmaceutiquement acceptable. L'invention concerne également un procédé de prévention, de traitement, de réduction de la durée, ou de réduction de la gravité de symptômes du rhume banal, dans lequel un patient ayant besoin d'un traitement pour la prévention, le traitement, la réduction de la durée ou la réduction de la gravité des symptômes du rhume banal. La composition pharmaceutique peut ensuite être administrée par voie orale au patient.
Also published as
Latest bibliographic data on file with the International Bureau